Giani Bisogno from the Haematology Oncology Division, Department of Women’s and Children’s Health, University of Padova, Padova, Italy on behalf of the the European paediatric Soft tissue sarcoma Study Group (EpSSG) have just pubisehd in the Lancet Oncology a randomized trial entitled: Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.. The publications (...)